Concepedia
Statistics
Publications
45
Citations
2.9K
H-Index
30
Active since
1992
Affiliations
AstraZeneca (United Kingdom)(Current)
Institute of Cancer Research
University of Cambridge
Sungkyunkwan University
Samsung Medical Center
Simon A. Smith is an author at AstraZeneca (United Kingdom) specializing in medicine, oncology, and pathology.
Top concepts
MedicineOncologyGeneticsPathologyRadiation OncologyCancer GeneticsCancer TherapyCell BiologyTumor BiologyOvarian Cancer
Publications per year
1992–2024
Allele losses in the region 17q12–21 in familial breast and ovarian cancer involve the wild–type chromosome
Simon A. Smith, Douglas F. Easton, D. Gareth Evans et al. · Nature Genetics · 1992 · 414 citations
Allelic Variant, Cytogenetics, Genetics +8
An evaluation of genetic heterogeneity in 145 breast-ovarian cancer families. Breast Cancer Linkage Consortium.
S A Narod, Deborah Ford, Peter Devilee et al. · PubMed · 1995 · 265 citations
A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome
Richard Wooster, Jonathan Mangion, Rosalind A. Eeles et al. · Nature Genetics · 1992 · 251 citations
Breast Oncology, Mendelian Disorder, Hormonal Receptor +7
Ceralasertib (AZD6738), an Oral ATR Kinase Inhibitor, in Combination with Carboplatin in Patients with Advanced Solid Tumors: A Phase I Study
Timothy A. Yap, Matthew Krebs, Sophie Postel‐Vinay et al. · Clinical Cancer Research · 2021 · 125 citations · Full text
Combination ATR and PARP Inhibitor (CAPRI): A phase 2 study of ceralasertib plus olaparib in patients with recurrent, platinum-resistant epithelial ovarian cancer
Payal D. Shah, Stephanie L. Wethington, Cheyenne Pagan et al. · Gynecologic Oncology · 2021 · 111 citations · Full text
1–5 of 45